| Date | Time | Source | Headline | Symbol | Company |
| 09/21/2009 | 8:00AM | Business Wire | Incyte Announces Positive Top-Line Phase IIb Results for Topical INCB18424 in Psoriasis | NASDAQ:INCY | Incyte Corporation |
| 09/18/2009 | 5:19PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:INCY | Incyte Corporation |
| 09/09/2009 | 7:08AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of GLBL, LAMR, INCY, NPBC, ONXX and KERX | NASDAQ:INCY | Incyte Corporation |
| 09/03/2009 | 5:00PM | Business Wire | Incyte to Present at Upcoming Investor Conferences | NASDAQ:INCY | Incyte Corporation |
| 08/25/2009 | 5:22AM | Marketwired | TheFortuneFinancial.com Free Market Research on ANSS, DISH, WTSLA, HBAN, MEDX and INCY | NASDAQ:INCY | Incyte Corporation |
| 08/11/2009 | 7:53AM | Marketwired | RothmanResearch.com Stock Review for AMTD, CAKE, FFIV, GRMN, INCY and HCBK | NASDAQ:INCY | Incyte Corporation |
| 07/30/2009 | 4:22PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:INCY | Incyte Corporation |
| 07/30/2009 | 7:22AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INCY | Incyte Corporation |
| 07/30/2009 | 7:00AM | Business Wire | Incyte Reports Second Quarter 2009 Financial Results and Provides Update on Drug Development Programs | NASDAQ:INCY | Incyte Corporation |
| 07/21/2009 | 7:43AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INCY | Incyte Corporation |
| 07/21/2009 | 7:30AM | Business Wire | Incyte Reaches Agreement with FDA on a Special Protocol Assessment for INCB18424 in Myelofibrosis | NASDAQ:INCY | Incyte Corporation |
| 07/15/2009 | 4:15PM | Business Wire | Incyte to Report Second Quarter 2009 Financial Results andProvide Update on Drug Discovery & Development Programs on July 30 | NASDAQ:INCY | Incyte Corporation |
| 07/14/2009 | 8:16AM | Marketwired | StreetInvesting.com Free Research on KLIC, ARCC, INCY, FORM, ACLS and DRIV | NASDAQ:INCY | Incyte Corporation |
| 06/29/2009 | 8:39AM | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on PH, BHI, AKRX, INCY, IACI and HBAN | NASDAQ:INCY | Incyte Corporation |
| 06/16/2009 | 4:35PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:INCY | Incyte Corporation |
| 06/16/2009 | 4:34PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:INCY | Incyte Corporation |
| 06/16/2009 | 4:34PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:INCY | Incyte Corporation |
| 06/09/2009 | 7:57AM | Marketwired | TheFortuneFinancial.com Free Market Research on HMC, HXL, IACI and INCY | NASDAQ:INCY | Incyte Corporation |
| 05/28/2009 | 4:46PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INCY | Incyte Corporation |
| 05/28/2009 | 4:30PM | Business Wire | Incyte Provides Update on Special Protocol Assessment for INCB18424 as a New Treatment for Myelofibrosis | NASDAQ:INCY | Incyte Corporation |
| 05/26/2009 | 4:15PM | Business Wire | Incyte to Present at Goldman Sachs 30th Annual Global Healthcare Conference | NASDAQ:INCY | Incyte Corporation |
| 05/21/2009 | 4:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 05/21/2009 | 4:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 05/21/2009 | 4:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 05/21/2009 | 4:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 05/21/2009 | 4:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 05/21/2009 | 4:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 05/21/2009 | 4:15PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INCY | Incyte Corporation |
| 05/07/2009 | 4:31PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:INCY | Incyte Corporation |
| 05/07/2009 | 7:41AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INCY | Incyte Corporation |